Home > Qtrly Results > AJANTA PHARMA

AJANTA PHARMA
Quarterly Results Analysis [Sep2024]

AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Quarterly Results

Consolidated Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Revenues ₹1,187 Cr ₹1,145 Cr ₹1,054 Cr ₹1,105 Cr ₹1,028 Cr ₹1,021 Cr ₹882 Cr ₹972 Cr
Expenses ₹875 Cr ₹815 Cr ₹776 Cr ₹791 Cr ₹738 Cr ₹750 Cr ₹732 Cr ₹802 Cr
Operating Income ₹311 Cr ₹330 Cr ₹278 Cr ₹314 Cr ₹291 Cr ₹271 Cr ₹149 Cr ₹170 Cr
Other Income ₹19 Cr ₹26 Cr ₹36 Cr ₹14 Cr ₹21 Cr ₹32 Cr ₹37 Cr ₹35 Cr
Interest ₹6 Cr ₹1 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹1 Cr ₹1 Cr ₹3 Cr
Depreciation ₹34 Cr ₹34 Cr ₹34 Cr ₹34 Cr ₹34 Cr ₹33 Cr ₹33 Cr ₹33 Cr
Profit Before Tax ₹290 Cr ₹322 Cr ₹278 Cr ₹291 Cr ₹276 Cr ₹269 Cr ₹152 Cr ₹168 Cr
Profit After Tax ₹216 Cr ₹246 Cr ₹203 Cr ₹210 Cr ₹195 Cr ₹208 Cr ₹122 Cr ₹135 Cr
EPS ₹17.27 ₹19.61 ₹16.04 ₹16.62 ₹15.46 ₹16.47 ₹9.68 ₹10.46
Industry Peers & Returns1W1M1Y
AJANTA PHARMA -0.9% -0.5% 45%
SUN PHARMACEUTICAL INDUSTRIES -0% 0.5% 46.9%
CIPLA -2.1% -6.9% 19.3%
DR REDDYS LABORATORIES -0.6% -3.3% 7.4%
ZYDUS LIFESCIENCES -1.9% 0.7% 54.5%
DIVIS LABORATORIES -3% 0.9% 61.2%
MANKIND PHARMA 2.5% 0.2% 34.3%
TORRENT PHARMACEUTICALS -0.1% 5.6% 64.3%
LUPIN -0.7% 1.6% 73.6%

AJANTA PHARMA Quarterly Revenues

Revenues
Q-o-Q

3.64 %

Y-o-Y

15.38 %

Quarters Revenues % Change
Sep2024 ₹1,187 Cr
3.64
Jun2024 ₹1,145 Cr
8.62
Mar2024 ₹1,054 Cr
-4.62
Dec2023 ₹1,105 Cr
7.46
Sep2023 ₹1,028 Cr
0.72
Jun2023 ₹1,021 Cr
15.79
Mar2023 ₹882 Cr
-9.25
Dec2022 ₹972 Cr -

AJANTA PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-5.81 %

Y-o-Y

7.06 %

Quarters Operating Profit % Change
Sep2024 ₹311 Cr
-5.81
Jun2024 ₹330 Cr
18.69
Mar2024 ₹278 Cr
-11.38
Dec2023 ₹314 Cr
8.05
Sep2023 ₹291 Cr
7.13
Jun2023 ₹271 Cr
81.64
Mar2023 ₹149 Cr
-11.90
Dec2022 ₹170 Cr -
Operating Margins
Q-o-Q

-9.12 %

Y-o-Y

-7.22 %

Quarters Operating Margin% % Change
Sep2024 26.22%
-9.12
Jun2024 28.85%
9.28
Mar2024 26.4%
-7.11
Dec2023 28.42%
0.57
Sep2023 28.26%
6.36
Jun2023 26.57%
56.85
Mar2023 16.94%
-2.92
Dec2022 17.45% -

AJANTA PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-11.92 %

Y-o-Y

10.84 %

Quarters Profit After Tax % Change
Sep2024 ₹216 Cr
-11.92
Jun2024 ₹246 Cr
21.24
Mar2024 ₹203 Cr
-3.48
Dec2023 ₹210 Cr
7.54
Sep2023 ₹195 Cr
-6.16
Jun2023 ₹208 Cr
70.24
Mar2023 ₹122 Cr
-9.11
Dec2022 ₹135 Cr -
PAT Margins
Q-o-Q

-15.04 %

Y-o-Y

-3.95 %

Quarters PAT Margin(%) % Change
Sep2024 18.24 %
-15.04
Jun2024 21.47 %
11.65
Mar2024 19.23 %
1.21
Dec2023 19 %
0.05
Sep2023 18.99 %
-6.82
Jun2023 20.38 %
47.04
Mar2023 13.86 %
0.14
Dec2022 13.84 % -

AJANTA PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-11.93 %

Y-o-Y

11.71 %

Quarters EPS % Change
Sep2024 ₹17.27
-11.93
Jun2024 ₹19.61
22.26
Mar2024 ₹16.04
-3.49
Dec2023 ₹16.62
7.50
Sep2023 ₹15.46
-6.13
Jun2023 ₹16.47
70.14
Mar2023 ₹9.68
-7.46
Dec2022 ₹10.46 -

You may also like the below Video Courses